🔎 Trials Near Me

Home › Degenerasyon ng Macula › Virginia

Pag-aaral pangklinika para sa Degenerasyon ng Macula sa Virginia

6 pag-aaral para sa Degenerasyon ng Macula ang naghahanap ng mga kalahok sa mga site sa Virginia.

Mga Lungsod sa Virginia

Opisyal na teksto ng pag-aaral (English)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Southeastern Retina Associates, Bristol
  • Retina Group of Washington, Fairfax
  • Piedmont Eye Center, Lynchburg
  • at 1 pa
Nagre-recruitPhase 3
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06541704

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Piedmont Eye Center, Lynchburg
  • Wagner Kapoor Research institute, Norfolk
Nagre-recruitPhase 2/3
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06635148

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Piedmont Eye Center (Site 054), Lynchburg
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07440225

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Piedmont Eye Center, Lynchburg
Nagre-recruitPhase 2
Edad 55 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06659445

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

  • Wagner Macula & Retina Center, Norfolk
Nagre-recruitObservasyonal na pag-aaral
Edad 50 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06346600

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • Vistar Eye Center (Site 129), Roanoke
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07496567

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.